Skip to Main content Skip to Navigation
Master Thesis

Effets cardiaques de la trimetazidine : revue de la littérature

Abstract : The cardiovascular diseases and especially ischemic heart disorders (IHD) are a major problem of public health. Their cost for the society remains very important in spite of a very large therapeutic armory. Trimetazidine (TMZ) is one of the most ancient treatments of IHD use of which seems currently denigrated. We therefore wanted to assess its effects by searching different studies relating to this molecule. Of this study of literature we cleared several elements. TMZ remains rather often prescribed (a little more than 13 %). But especially many studies reveal his advantageous effect in post-ischemic recovery and in the repetition of angina. Moreover, new studies note a reduction of the risk of fibrillation induced by ischemia. However, these recent studies are accomplished on small cohorts. So it seems necessary to order larger studies to confirm or to preempt these results.
Document type :
Master Thesis
Complete list of metadata

Cited literature [140 references]  Display  Hide  Download
Contributor : Jean-Hugues Morneau Connect in order to contact the contributor
Submitted on : Wednesday, October 12, 2011 - 4:45:35 PM
Last modification on : Tuesday, May 11, 2021 - 11:36:16 AM
Long-term archiving on: : Friday, January 13, 2012 - 3:11:41 AM


  • HAL Id : dumas-00631573, version 1
  • PPN : 155608908


Hélène Beaumont. Effets cardiaques de la trimetazidine : revue de la littérature. Médecine humaine et pathologie. 2009. ⟨dumas-00631573⟩



Record views


Files downloads